Covid Vaccine Making in Africa Faces Setback on Lack of Orders

April 14, 2022, 1:23 PM UTC

African efforts to produce Covid-19 vaccines on the continent may face a setback amid a dearth of orders for the injections.

Aspen Pharmacare Holdings Ltd. informed the Africa Centres for Disease Control and Prevention it’s concerned about a lack of requests for Covid-19 vaccines and may close that manufacturing line if nothing changes, the head of the African Union’s public health agency said.

The continent’s biggest drugmaker is making the doses on behalf of Johnson & Johnson at a plant in South Africa and in March said it agreed to make those shots under its own brand. The Durban-based company ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.